|

DDI Probe Cocktail Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Exelixis1

Indications

  • Drug-Drug Interaction (DDI)1
  • Liver Disease1
  • Non-Clear Cell Renal Cell Carcinoma (nccRCC)1
  • Urothelial Carcinoma (UC)1
  • Clear Cell Renal Cell Carcinoma (ccRCC)1

Phoenix, Arizona1 trial

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #67

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.